Be alert for these biotech red flags
Biotech stock volatility shouldn't deter investors, because the potential to make money is just as significant. But investors…
Biotech stock volatility shouldn't deter investors, because the potential to make money is just as significant. But investors will need a strong stomach, especially those in for the short term.
Among established biotechs, says Rafael Tamargo, vice president and director of research at Wilmington Tr
Learn more about reprints and licensing for this article.
